This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / DSM-Firmenich €540M Share Repurchase Progress
Business Share repurchase

DSM-Firmenich €540M Share Repurchase Progress

Analysis based on 7 articles · First reported Mar 12, 2026 · Last updated Mar 17, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The share repurchase program by DSM-Firmenich is generally seen as a positive signal to the market, potentially boosting shareholder value and indicating financial strength. It directly impacts the company's stock on Euronext Amsterdam by reducing the number of outstanding shares.

Specialty chemicals Nutrition Health
Event Summary

DSM-Firmenich, a Swiss company listed on Euronext Amsterdam, announced on February 9, 2026, its intention to repurchase ordinary shares with an aggregate market value of €500 million to reduce its issued capital. On March 12, 2026, the company commenced a share repurchase program for a total amount of €540 million. Of this, €40 million is allocated to cover commitments under the Group's share-based compensation plans, and €500 million is for reducing its issued capital. As of March 13, 2026, 175,408 shares have been repurchased at an average price of €58.21 per share, totaling €10.2 million. The program is expected to be completed by the end of Q3 2026.

Key Actions
90 DSM-Firmenich commenced share repurchase program
80 DSM-Firmenich announced intention to repurchase shares
Entities Involved
stock
DSM-Firmenich
DSM-Firmenich announced and commenced a share repurchase program totaling €540 million, with €500 million aimed at reducing issued capital and €40 million for share-based compensation plans. This action is generally viewed positively by the market as it can increase shareholder value.
Importance 100 Sentiment 20
exch
Euronext Amsterdam
DSM-Firmenich is listed on Euronext Amsterdam, where its shares are being repurchased as part of the program.
Importance 10 Sentiment 0
cnt
Switzerland
DSM-Firmenich is a Swiss company, indicating its country of origin and primary legal jurisdiction.
Importance 5 Sentiment 0
cnt
Netherlands
Maastricht, Netherlands, is mentioned as a location related to the company's operations or announcement.
Importance 5 Sentiment 0
Relationships
DSM-Firmenich related ↔ Switzerland
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.